Infliximab in the treatment of Crohn’s disease

The recent introduction of infliximab, a chimeric monoclonal antibody against tumor necrosis factor-α, has greatly modified the treatment of Crohn’s disease (CD). Data from the literature show encouraging results after intravenous infusion both for closure of intestinal or perianal fistulas and for...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Poggioli, Gilberto, Laureti, Silvio, Campieri, Massimo, Pierangeli, Filippo, Gionchetti, Paolo, Ugolini, Federica, Gentilini, Lorenzo, Bazzi, Piero, Rizzello, Fernando, Coscia, Maurizio
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2007
Ämnen:
Reviews
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1936311/
https://ncbi.nlm.nih.gov/pubmed/18360638
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk